A citation-based method for searching scientific literature

E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
Times Cited: 50







List of co-cited articles
421 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
68



Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
339
50



2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
34



Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
603
28

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
53
28

Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).
Maurizio Volterrani, Gennaro Cice, Giuseppe Caminiti, Cristiana Vitale, Salvatore D'Isa, Pasquale Perrone Filardi, Flavio Acquistapace, Giuseppe Marazzi, Massimo Fini, Giuseppe M C Rosano. Int J Cardiol 2011
81
26

Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
285
26

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Jean-Claude Tardif, Eileen O'Meara, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
204
24

Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
139
24

Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
652
22

Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure.
Filippo M Sarullo, Giovanni Fazio, Danilo Puccio, Sergio Fasullo, Salvatore Paterna, Salvatore Novo, Pietro Di Pasquale. J Cardiovasc Pharmacol Ther 2010
43
25


Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
Caroline A Daly, Felicity Clemens, Jose L Lopez Sendon, Luigi Tavazzi, Eric Boersma, Nicolas Danchin, François Delahaye, Anselm Gitt, Desmond Julian, David Mulcahy,[...]. Postgrad Med J 2010
32
31

The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
40
25

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
Inger Ekman, Olivier Chassany, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
139
18



Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
Michal Tendera, Mario Talajic, Michele Robertson, Jean-Claude Tardif, Roberto Ferrari, Ian Ford, P Gabriel Steg, Kim Fox. Am J Cardiol 2011
26
34

Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL.
C Ceconi, S B Freedman, J C Tardif, P Hildebrandt, T McDonagh, P Gueret, G Parrinello, M Robertson, P G Steg, M Tendera,[...]. Int J Cardiol 2011
60
16

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
539
16

Ivabradine for the treatment of stable angina pectoris in octogenarians.
Ralf Koester, Jan Kaehler, Thomas Meinertz. Clin Res Cardiol 2011
20
40

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Paul Mulder, Stephane Barbier, Abdeslam Chagraoui, Vincent Richard, Jean Paul Henry, Françoise Lallemand, Sylvanie Renet, Guy Lerebours, Florence Mahlberg-Gaudin, Christian Thuillez. Circulation 2004
245
16

Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine.
Annalisa Bucchi, Mirko Baruscotti, Dario DiFrancesco. J Gen Physiol 2002
192
16



Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.
Patrice Colin, Bijan Ghaleh, Luc Hittinger, Xavier Monnet, Michel Slama, Jean-François Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2002
73
16



Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
68
16

Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
21
38

Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.
C Thollon, S Bedut, N Villeneuve, F Cogé, L Piffard, J-P Guillaumin, C Brunel-Jacquemin, P Chomarat, J-A Boutin, J-L Peglion,[...]. Br J Pharmacol 2007
69
14

Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting.
Francine C Wiest, Chris L Bryson, Marcia Burman, Mary B McDonell, Jorja G Henikoff, Stephan D Fihn. Am J Med 2004
39
17

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
Ralf Koester, Jan Kaehler, Henning Ebelt, Gerold Soeffker, Karl Werdan, Thomas Meinertz. Clin Res Cardiol 2010
20
35

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
198
14

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
Finlay A McAlister, Natasha Wiebe, Justin A Ezekowitz, Alexander A Leung, Paul W Armstrong. Ann Intern Med 2009
350
14

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
John J V McMurray, Stamatis Adamopoulos, Stefan D Anker, Angelo Auricchio, Michael Böhm, Kenneth Dickstein, Volkmar Falk, Gerasimos Filippatos, Cândida Fonseca, Miguel Angel Gomez-Sanchez,[...]. Eur Heart J 2012
14

Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
35
20

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
Kim Fox, Michel Komajda, Ian Ford, Michele Robertson, Michael Böhm, Jeffrey S Borer, Philippe Gabriel Steg, Luigi Tavazzi, Michal Tendera, Roberto Ferrari,[...]. Eur Heart J 2013
63
14

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
14


Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)
N Rehnqvist, P Hjemdahl, E Billing, I Björkander, S V Eriksson, L Forslund, C Held, P Näsman, N H Wallén. Eur Heart J 1996
171
12

Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
Patrice Colin, Bijan Ghaleh, Xavier Monnet, Jinbo Su, Luc Hittinger, Jean-Francois Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2003
106
12




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.